|
Form Serial Number: |
DA20210705E00417
|
1.
Date of relevant event: |
30/06/2021 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
01873 |
4.
Name of listed corporation: |
Viva Biotech Holdings |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
1,926,934,348 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Hua |
(Other names) |
Fengmao |
|
|
|
10.
Name of director (Chinese): |
華風茂 |
11.
Chinese Character Code as printed on HKID Card: |
547873645399 |
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1706 | Miscellaneous Notice filed because you ceased to be a director or chief executive of the listed corporation | |
2501 | Other (you must describe the capacity in the Supplementary Information box) | |
2501 | Other (you must describe the capacity in the Supplementary Information box) | |
98,240,919 |
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 98,880,919 | 5.13 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 98,240,919 | 5.10 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
| |
2305 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4105 | Unlisted derivatives - Physically settled |
| 02/01/2020 | 01/01/2022 | USD | 0 | USD | 0.123 | | | 6,144,753 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
China Finance Strategies Investment DB Limited | Mandar House, 3rd Floor, Johnson's Ghut, Tortola, British Virgin Islands | HUA Fengmao | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
Vivastar Trust Scheme | Addresses of individuals are not displayed. | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Notice filed because Mr. HUA Fengmao ceased to be a director of Viva Biotech Holdings on June 30, 2021, but remains as a substantial shareholder. Please refer to box 27 regarding the capacity in which the shares are held. Since Mr. HUA has resigned from the Company, the 640,000 Shares underlying the restricted share units granted under the Viva Biotech Holdings Restricted Share Unit Scheme has lapsed automatically pursuant to the rules of the scheme.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
0
|
Date of filing this Form 3A: |
05/07/2021 (dd/mm/yyyy)
|
|